Dyne's shares surge after promising data on muscle disorder treatment

Shares of drug developer Dyne Therapeutics (DYN.O) doubled in premarket trading on Wednesday after its experimental therapy for a muscle-wasting disorder showed promise in a small, early-stage trial.